Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vanguard Index FdsTotal Stock Market | 0 | 1,038,550 | +1,038,550 | $0 | $277.82M | 14.98% | +$277.82M |
| Brookfield CorporationCL A(BN) | 3,880,230 | 3,880,230 | 0 | $162.47M | $161.18M | 8.69% | -$1.28M |
| Tempus AI, Inc.CL A(TEM) | 0 | 4,074,419 | +4,074,419 | $0 | $142.60M | 7.69% | +$142.60M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 182,536 | 133,336 | -49,200 | $177.15M | $136.37M | 7.35% | -$40.78M |
| Salesforce, Inc.(CRM) | 480,160 | 480,160 | 0 | $144.61M | $123.45M | 6.66% | -$21.17M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 6,344,430 | +6,344,430 | $0 | $114.26M | 6.16% | +$114.26M |
| Corcept Therapeutics Incorporated(CORT) | 2,411,362 | 2,411,362 | 0 | $60.74M | $78.35M | 4.22% | +$17.60M |
| Vaxcyte, Inc.(PCVX) | 845,000 | 950,000 | +105,000 | $57.72M | $71.73M | 3.87% | +$14.01M |
| Insmed Incorporated(INSM) | 1,339,304 | 800,000 | -539,304 | $36.34M | $53.60M | 2.89% | +$17.26M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,500,000 | 1,500,000 | 0 | $37.68M | $51.28M | 2.76% | +$13.61M |
| Crinetics Pharmaceuticals In | 1,098,600 | 1,000,000 | -98,600 | $51.43M | $44.79M | 2.41% | -$6.64M |
| Cable One, Inc.(CABO) | 118,403 | 118,403 | 0 | $50.10M | $41.91M | 2.26% | -$8.19M |
| BioMarin Pharmaceutical Inc.(BMRN) | 450,000 | 490,000 | +40,000 | $39.30M | $40.34M | 2.17% | +$1.04M |
| Merus N V | 0 | 675,000 | +675,000 | $0 | $39.94M | 2.15% | +$39.94M |
| Apple Inc.(AAPL) | 182,960 | 182,960 | 0 | $31.37M | $38.54M | 2.08% | +$7.16M |
| Alibaba Group Holding LimitedADS(BABA) | 500,827 | 500,827 | 0 | $36.24M | $36.06M | 1.94% | -$180.3K |
| Pharvaris N V COM | 1,168,030 | 1,725,000 | +556,970 | $26.99M | $32.43M | 1.75% | +$5.44M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 850,000 | +850,000 | $0 | $31.46M | 1.70% | +$31.46M |
| 4d Molecular Therapeutics In | 1,400,000 | 1,400,000 | 0 | $44.60M | $29.39M | 1.58% | -$15.22M |
| LanzaTech Global, Inc.(LNZA) | 15,814,845 | 15,814,845 | 0 | $48.95M | $29.26M | 1.58% | -$19.69M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 118,383 | 118,383 | 0 | $17.69M | $28.77M | 1.55% | +$11.07M |
| ArriVent BioPharma, Inc.(AVBP) | 1,077,140 | 1,500,000 | +422,860 | $19.24M | $27.82M | 1.50% | +$8.59M |
| Viridian Therapeutics, Inc.(VRDN) | 1,100,000 | 2,000,000 | +900,000 | $19.26M | $26.02M | 1.40% | +$6.76M |
| Cargo Therapeutics Inc | 1,250,000 | 1,544,000 | +294,000 | $27.90M | $25.35M | 1.37% | -$2.55M |
| Amicus Therapeutics Inc COM | 2,500,000 | 2,500,000 | 0 | $29.45M | $24.80M | 1.34% | -$4.65M |
| Brookfield Asset Management Ltd.CL A(BAM) | 627,207 | 627,207 | 0 | $26.36M | $23.87M | 1.29% | -$2.49M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,050,000 | 1,100,000 | +50,000 | $28.29M | $23.68M | 1.28% | -$4.60M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,638,298 | 1,450,500 | -187,798 | $25.69M | $23.27M | 1.25% | -$2.42M |
| Blueprint Medicines Corp | 358,626 | 175,000 | -183,626 | $34.02M | $18.86M | 1.02% | -$15.16M |
| Kyverna Therapeutics, Inc.(KYTX) | 700,000 | 1,750,000 | +1,050,000 | $17.39M | $13.13M | 0.71% | -$4.26M |
| Morphic Hldg Inc | 0 | 375,000 | +375,000 | $0 | $12.78M | 0.69% | +$12.78M |
| Verve Therapeutics Inc | 2,000,000 | 2,400,000 | +400,000 | $26.56M | $11.71M | 0.63% | -$14.85M |
| Metagenomi Therapeutics, Inc.(MGX) | 1,739,175 | 1,800,000 | +60,825 | $18.35M | $7.34M | 0.40% | -$11.00M |
| Io Biotech Inc | 5,088,258 | 4,429,449 | -658,809 | $8.80M | $5.18M | 0.28% | -$3.62M |
| AbCellera Biologics Inc.(ABCL) | 1,126,915 | 1,126,915 | 0 | $5.10M | $3.34M | 0.18% | -$1.77M |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $2.63M | $2.42M | 0.13% | -$211.9K |
| Galecto Inc | 2,497,791 | 2,497,791 | 0 | $1.95M | $1.18M | 0.06% | -$764.3K |
| Spero Therapeutics, Inc.(SPRO) | 468,902 | 468,902 | 0 | $806.5K | $609.6K | 0.03% | -$196.9K |
| Edgewell Personal Care Company(EPC) | 6,344,430 | 0 | -6,344,430 | $115.72M | $0 | — | -$115.72M |
| Inspire Medical Systems, Inc.(INSP) | 65,524 | 0 | -65,524 | $14.07M | $0 | — | -$14.07M |
| Treace Medical Concepts, Inc.(TMCI) | 360,000 | 0 | -360,000 | $4.70M | $0 | — | -$4.70M |